Aims: To characterize the relationship between diabetic retinopathy (DR) and diabetic nephropathy (DN) in Chinese patients and to determine whether the severity of DR predicts end-stage renal disease (ESRD). Methods: Bilateral fundic photographs of 91 Chinese type 2 diabetic patients with biopsy-confirmed DN, not in ESRD stage, were obtained at the time of renal biopsy in this longitudinal study. The baseline severity of DR was determined using the Lesionaware Deep Learning System (RetinalNET) in an open framework for deep learning and was graded using the Early Treatment Diabetic Retinopathy Study Severity Scale. Cox proportional hazard models were used to estimate the hazard ratio (HR) for the effect of the severity of diabetic retinopathy on ESRD. Results: During a median follow-up of 15 months, 25 patients progressed to ESRD.
Introduction
Diabetic retinopathy (DR) and diabetic nephropathy (DN) are two of the three major microvascular complications in patients with diabetes mellitus (DM). Paralleling the dramatic rise in the prevalence of diabetes mellitus, DN has become the leading cause of end-stage renal disease (ESRD) in Chinese people (1) , and DR has become the leading cause of blindness worldwide (2) . Epidemiologic studies have identified a close relationship between DR and DN, which implies that DR may be useful as a noninvasive predictor of DN (3) . Several previous studies had been designed to explore the relationship between DR and renal outcomes in patients with DN, but no definitive conclusion can be drawn from these. In two Chinese studies, DR at the time of biopsy was shown to have a hazard ratio (HR) of 1.69 for ESRD (4) and was associated with a more rapid decline in estimated glomerular filtration rate (eGFR) in unbiopsied patients with type 2 diabetes mellites (T2DM). However, in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial conducted in the US, there was no significant relationship between moderate/severe DR and ESRD in unbiopsied patients with T2DM (5) . Finally, a study conducted in unbiopsied Chinese patients with diabetes found the prevalence of non-diabetic renal disease (NDRD) to be 35% (6) . The natural history of DN may differ in different populations; therefore, the association between DR and DN identified elsewhere may not be present in Chinese patients. Consequently, we wished to characterize the relationship between DR and DN in Chinese patients with DOI:10.4158/EP-2019-0512 © 2020 AACE biopsy-confirmed DN.
The conventional evaluation for DR is performed by ophthalmologists using fundic photography or retinal imaging. However, the results of screening for early retinopathy are highly variable. Artificial intelligence and automated image processing have been successfully used in a number of disciplines. Screening for DR using a deep learning system has become a universally accepted strategy for blindness prevention.
Morphological component analysis can easily differentiate the features of DR, such as microaneurysm, hemorrhage, and exudate (7) . In our previous study, we found that the presence of DR is an independent risk factor for diabetic ESRD. However, whether the severity of DR, rather than just its presence or absence, which can be determined by the combination of artificial intelligence and an ophthalmologist, can predict the risk of ESRD in patients with biopsy-confirmed DN remains unclear.
This study aimed to 1) classify DR as mild, moderate, or severe non-proliferative, or proliferative, according to the international classification, by artificial intelligence and an ophthalmologist, in Chinese patients with biopsy-confirmed DN; 2) determine whether the severity of DR at the time of biopsy can predict progression to ESRD; and
3) characterize the relationship between DR and DN in patients with DN. The indications for renal biopsy were T2DM and renal damage, with no absolute contraindication. Typically, it was performed in T2DM patients with obvious glomerular hematuria and/or a short duration of diabetes, or with sudden onset overt proteinuria (8). T2DM was diagnosed in accordance with the American Diabetes Association criteria (9). DN was defined using the standard published by An et al. (10) in 2015 and was diagnosed by at least two renal pathologists and/or nephrologists on the basis of the Renal Pathology Society (RPS) classification (11). Adult patients with T2DN and biopsy-confirmed DN who had undergone retinal fundus photography and were followed-up at our hospital for ≥ 3 months were considered to be eligible for this study. The exclusion criteria were co-existing non-diabetic renal diseases (NDRD), such as membranous nephropathy or IgA nephropathy; or systemic diseases, especially those involving antineutrophil cytoplasmic antibodies (ANCA), such as vasculitis, antiglomerular basement membrane disease and lupus nephritis; non-type 2 diabetes, progression to ESRD before renal biopsy; and missing retinal data at the time of biopsy DOI:10.4158/EP-2019-0512 © 2020 AACE ( Supplementary Fig. 1 ).
Material and methods

Patient selection and study design
Baseline diabetic retinopathy classification by artificial intelligence
Color photographs of each retina were obtained using the methodology of the ACCORD Eye Study (12). Bilateral color fundic photographs were obtained at 45° using a fundus camera (Canon, CR-2, Japan) at the time of renal biopsy, analyzed using the We classified the severity of the retinopathy as absent (step 0), mild non-proliferative diabetic retinopathy (NPDR) (steps 2-5), moderate NPDR (steps 6-9), severe NPDR (steps 10-11), or advanced proliferative diabetic retinopathy (PDR) (steps 12 and above) (14) . For the purposes of classification, if the severity of retinopathy could not be graded in an eye, it was considered to be equal to that in the other eye. For a single patient, the higher grade in either eye was used to define the severity of retinopathy.
Digital ophthalmoscopic images were interpreted by an ophthalmologist (Y.C.) who was blinded to the medical history of the patient.
Clinical and laboratory information
DOI:10.4158/EP-2019-0512 © 2020 AACE Baseline demographics and clinical information at the time of renal biopsy were extracted from the hospital's electronic medical records system. eGFR was evaluated using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) formula (15) . Baseline albuminuria was categorized as normoalbuminuria (<30 mg/g creatinine [category A1]), microalbuminuria (30 and <300 mg/g creatinine [category A2]), and macroalbuminuria (300 mg/g creatinine [category A3]) (16) . We classified proteinuria in patients in whom albuminuria was not evaluated as normal proteinuria (<0.15 g/day [category A1]), mild proteinuria (0.15 and <0.5 g/day [category A2]), and severe proteinuria(0.5 g/day [category A3]), as suggested by Shimizu et al. (17) When these results were inconsistent, urinary albumin excretion was given priority. Hematuria was diagnosed when more than five erythrocytes were present per high-power field in at least two of three consecutive urine samples, in the absence of urinary infection, urinary tract malignancy, and urolithiasis (18) . Hemoglobin A1c (HbA1c) was directly measured from fasting venous blood samples using quantitative high-performance liquid chromatography and the boronated affinity method (Bio-Rad D-10 Hemoglobin Analyzer). Use of renin-angiotensin-aldosterone system (RAAS) blockade, or statins for more than half of the follow-up period was recorded. The patents attended followup appointments 2-4 times annually, depending on their clinical condition. Detailed follow-up data were collected and recorded in the follow-up information system. The renal outcome was defined as the progression to ESRD, indicated by an eGFR <15 mL/min/1.73m2, or the use of renal replacement therapy (19) . All the patients were DOI:10.4158/EP-2019-0512 © 2020 AACE followed until December 31, 2018.
Pathological classification
Renal biopsy tissues were prepared for light microscopy, immunofluorescence, and electron microscopy using standard procedures at West China Hospital. Renal specimens were stained with hematoxylin-eosin, periodic acid-Schiff, Masson's trichrome, and periodic acid-Schiff silver methenamine. The original immunofluorescence microscopic and electron microscopy findings were used to confirm a diagnosis of DN. All the histopathological features were evaluated in light microscopy images using the RPS DN classification (11) by two nephropathologists (L.L., H.X.), who were blinded to the clinical data and renal outcomes. Survival curves for each DR stage were obtained using the Kaplan-Meier method and log-rank tests, then we used univariate and multivariable Cox proportional hazard models to explore the relationships between clinical or pathological parameters and ESRD. No patients were lost to follow-up. Data for urinary protein were missing for 3 individuals (3 were included in multivariable analyses). We first examined the differences in clinical parameters between patients with or without missing values to check if it was randomly missed. We then used multiple imputation methods for multivariable models. In multivariable Cox proportional hazard models, parameters with P<0.05 in the fully adjusted model were considered to be significant predictors of prognosis. Correlations between clinical parameters and pathological findings were evaluated using Spearman's correlation analyses.
Statistical analysis
All statistical analyses were performed using Stata version 14.0 (StataCorp LLC, College Station, TX, USA) or SAS version 9.4 (SAS Institute Inc.). Statistical significance was accepted at P<0.05.
Results
Relationships between diabetic retinopathy and renal outcomes
During the follow-up period, 25 (28%) patients progressed to ESRD. The percentages of patients without retinopathy, with mild NPDR, with moderate NPDR, DOI:10.4158/EP-2019-0512 © 2020 AACE with severe NPDR, and with PDR, who progressed to ESRD were 0, 9%, 30%, 46%, and 56%, respectively. The survival curves, depicting the time to ESRD, are shown in Figure 1 . Univariate Cox analysis showed that retinopathy significantly affects renal survival in patients with T2DM (HR 1.72, 95% confidence interval [CI] 1.28-2.31, P<0.001). Patients with PDR had poorer renal survival than those with NPDR (HR 3.45, 95% CI 1.28-9.32, P=0.02). After adjusting for age, sex, SBP, baseline eGFR, proteinuria, HbA1c, and pathological parameters, the severity of retinopathy remained an independent risk factor for ESRD (HR 2.18, 95% CI 1.05-4.53, P=0.04) ( Table 1) .
Baseline demographics and clinical characteristics
The clinical characteristics of the patients with and without retinal data are displayed in Supplementary Table 1 . The patients enrolled in this study had a longer duration of T2DM, higher cholesterol, and were more likely to have hematuria than those for whom retinal data was not available. A summary of the demographics and baseline characteristics of the 91 patients enrolled in the study is shown in Table 2 . The mean age of the participants was 51 years, and the group was composed of 23 women (25%) and 68 men (75%). The median duration of T2DM was 120 months (IQR, 72-156), the median baseline eGFR was 58.0 mL/min/1.73m2, and the median 24-h proteinuria was 3.55 g.
Of the total 91 patients, the prevalences were 17% for absence of retinopathy, 12% for mild NPDR, 47% for moderate NPDR, 14% for severe NPDR, and 10% for PDR. DOI:10.4158/EP-2019-0512 © 2020 AACE Compared with patients who did not have retinopathy, those with retinopathy had a higher incidence of hypertension, more severe proteinuria, and serum creatinine, but lower albumin and eGFR (P<0.05). The PDR group had the longest duration of diabetes and the highest concentration of serum creatinine (P<0.05). The hemoglobin and eGFR decreased, and systolic blood pressure (SBP) increased, in parallel with the severity of DR. There were no significant differences in diastolic blood pressure (DBP) or cholesterol among the five groups.
Relationship between retinopathy and renal function
In the full cohort of DN patients, we compared the characteristics of patients with and without retinopathy, classified according to their severity of albuminuria. There were 3 (3%) patients with normoalbuminuria, 12 (13%) patients with microalbuminuria, and 76 (84%) patients with macroalbuminuria. The prevalence and severity of retinopathy were associated with the severity of albuminuria, eGFR, and the severity of hematuria, but not with the duration of diabetes ( Figure 2 ). The prevalences of hematuria, hypertension, and ESRD were higher in patients with DR than in those without (Supplementary Table 2 ).
Further correlation analysis revealed that DR was negatively associated with albumin (r = −0.38, P<0.001), hemoglobin (r = −0.49, P<0.001), and eGFR (r = −0.34, P<0.01), but positively associated with SBP (r = 0.31, P<0.01), proteinuria (r = 0.36, P<0.01), and hematuria (r = 0.31, P<0.01). However, duration of diabetes and the DOI:10.4158/EP-2019-0512 © 2020 AACE baseline HbA1c were not significantly associated with retinopathy.
Relationships between retinopathy and features of renal pathology
As shown in Table 3 , the severity of glomerular lesions increased with the stage of retinopathy (P<0.001 for trend). For patients without retinopathy, the majority of the biopsy specimens showed mild changes, indicated by glomerular classifications of class I (33%) and class IIa (60.0%). 27 (30%) patients with mild or moderate retinopathy had severe glomerular lesions (class III or IV), whereas three (3%) patients with severe retinopathy (severe NPDR or PDR) had mild glomerular changes (class I or IIa) (Supplementary Table 3 ). These results imply a more heterogeneous manifestation of microvascular injury in patients with T2DM.
Further analysis showed that patients with mild or moderate NPDR had lower eGFR, hemoglobin, albumin, and HbA1c values, but more severe proteinuria and a higher low-density lipoprotein-cholesterol (LDL-C) concentration if they had severe glomerulopathy (class III or IV) than if they had mild glomerulopathy (class I or IIa).
In contrast, patients with severe retinopathy (severe NPDR and PDR) and mild glomerulopathy (class I or IIa) were more likely to have a longer duration of diabetes than those with severe glomerulopathy (class III or IV) ( Supplementary Table 3 ).
Among the 15 patients without retinopathy, 14 had mild glomerulopathy (class I or IIa) and only one patient had severe glomerulopathy (class IV), although they had normal albuminuria (24-h proteinuria 0.01 g/day). DOI:10.4158/EP-2019-0512 © 2020 AACE Significant correlations were identified between retinopathy and pathological parameters, including glomerular lesions (r = 0.53, P<0.001) and interstitial fibrosis and tubular atrophy (IFTA) (r = 0.32, P=0.003), suggesting that common pathogenetic mechanisms might exist for renal and retinal injury.
Discussion
Our previous study demonstrated that the presence of DR is an independent risk factor for renal outcomes (3). Here, we use an automatic grading system for DR that involves highly sensitive and efficient deep learning to categorize DR and show that its severity is significantly associated with the prevalence of diabetic ESRD in patients with T2DM and biopsy-confirmed DN. However, there was some discordance between the severity of DR and DN, especially in patients with mild retinopathy or microalbuminuria.
Several clinical studies have shown that DR is associated with a deterioration in renal function in patients with DN (3, 4) and in elderly people (20) . The present study has shown that retinopathy is strongly associated with pathological parameters, suggesting that common mechanisms are involved in the pathogenesis of renal and retinal injury. Indeed, protein kinase C (PKC), inflammation, and oxidative stress is considered to play a critical role in both retinopathy and nephropathy (21, 22) . A recent study even supported that local complement overactivation and complement proteins DOI:10.4158/EP-2019-0512 © 2020 AACE might be involved in the pathophysiology of retinopathy and nephropathy (23) .
Seven of the participants in the present study had received intravitreal antivascular endothelial growth factor (VEGF) treatment and three of these developed ESRD. Four participants had undergone laser photocoagulation, one of whom developed ESRD. The treatments for severe DR include laser photocoagulation and the intravitreal injection of VEGF inhibitor (24), but even when administered intravitreally, VEGF inhibitors can be systemically absorbed and have adverse effects on the kidneys.
These include the worsening of proteinuria, hypertension, glomerular lesions, clotting defects, and potentially long-term deleterious effects on renal function (25) . These effects of VEGF inhibitors are consistent with differing pathogenetic mechanisms for DR and DN, and imply that for patients with DR it is necessary to assess the severity of DN, in order to determine the timing of anti-VEGF injections, and to monitor renal function during inhibitor treatment (26) .
Several studies have shown that the presence of proteinuria is not only a marker of DN but also of DR (27) . However, we have found that DR and DN are not always consistent, especially in patients with microalbuminuria or mild retinopathy. In our cohort, ~50% of the participants who had mild retinopathy with advanced glomerular lesions had higher serum LDL-cholesterol and more severe proteinuria than those with mild glomerular lesions. Of the patients with advanced retinopathy, 14% had mild glomerular lesions (class I or IIa), and they were likely to have had diabetes for longer than the participants with severe glomerular lesions. These results are in keeping with DOI:10.4158/EP-2019-0512 © 2020 AACE the study by Song et al. (28) , which found that hyperglycemia is associated with DR progression, whereas dyslipidemia is associated with DN progression (28) .
Nevertheless, such inconsistency really precludes any conclusions regards to whether renal injury precedes retinal damage (29) .
Our results show a positive association between DR and hematuria. Hematuria 
